Phyton Biotech, a division of DFB Pharmaceuticals, was founded in 1990. Using its Plant Cell Fermentation (PCF) technology, Phyton Biotech is currently the world’s largest producer of high-quality paclitaxel and docetaxel. It offers clients a full range of integrated contract product and process development and commercial manufacturing services across the entire development chain, from feasibility to commercial production, to the pharmaceutical, cosmetic, agricultural and food ingredient industries. Its facilities in Germany and Canada have been inspected by multiple regulatory agencies and comply with international GMP requirements.
KEY PRODUCTS
World’s Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.
Related Companies
Market Place
